Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 176-179

  McCarron, Mark O ^a   Nicoll, James A R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; APOLIPOPROTEIN E; APOLIPOPROTEIN E2;

ALZHEIMER DISEASE; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN INJURY; CONFERENCE PAPER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; NECROSIS; RISK FACTOR; VASCULAR AMYLOIDOSIS;

EID: 0034019944     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06366.x     Document Type: Conference Paper

References (30)

1. 1. STRITTMATTER, W. et al. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
2. 2. SAUNDERS, A.M. et al. 1993. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
3. 3. NAMBA, Y. et al. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541: 163-166.
4. 4. VONSATTEL, J.P. et al. 1991. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann. Neurol. 30: 637-649.
5. 5. SCHMECHEL, D.E. et al. 1993. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 9649-9653.
6. 6. PREMKUMAR, D.R. et al. 1996. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 148: 2083-2095.
7. 7. OLICHNEY, J.M. et al. 1996. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47:190-196.
8. 8. GREENBERG, S.M. et al. 1995. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38: 254-259.
9. 9. ITOH, Y. et al. 1996. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke 27: 216-218.
10. 10. YAMADA, A.M. et al. 1987. Cerebral amyloid angiopathy in the aged. J. Neurol. 234: 371-376.
11. 11. NICOLL, J.A.R. et al. 1996. High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 39: 682-683.2.
12. 12. NICOLL, J.A.R. et al. 1997. High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann. Neurol. 41: 716-721.
13. 13. GREENBERG, S.M. et al. 1996. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27: 1333-1337.
14. 14. KALARIA, R.N. et al. 1995. Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet 346: 1424.
15. 15. CORDER, E.H. et al. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat.Genet. 7: 180-184.
16. 16. McCARRON, M.O. et al. 1998. High frequency of apolipoprotein E ε2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci. Lett. 247: 45-48.
17. 17. GREENBERG, S.M. et al. 1998. Association of apolipoprotein E ε2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50: 961-965.
18. 18. JELLINGER, K. 1977. Cerebrovascular amyloidosis with cerebral hemorrhage. J. Neurol. 214: 195-206.
19. 19. FERREIRO, J.A. et al. 1989. Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease. J. Neurol. 236: 267-272.
20. 20. OKAZAKI, H. et al. 1979. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin. Proc. 54: 22-31.
21. 21. GREENE, G.M. et al. 1990. Surgical experience with cerebral amyloid angiopathy. Stroke 21:1545-1549.
22. 22. SMITH, D.B. et al. 1985. Cerebral amyloid angiopathy presenting as transient ischemic attacks. Case report. J. Neurosurg. 63: 963-964.
23. 23. ANONYMOUS. 1996. Case records of the Massachusetts General Hospital. Weekly clinico-pathological exercises. Case 22-1996. Cerebral hemorrhage in a 69-year-old woman receiving warfarin. N. Engl. J. Med. 335:189-196.
24. 24. LEBLANC, R. et al. 1992. Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neurosurgery 31: 586-590.
25. 25. SLOAN, M.A. et al. 1995. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the thrombolysis in myocardial infarction (TIMI) II pilot and randomized clinical trial combined experience. Neurology 45: 649-658.
26. 26. McCARRON, M.O. et al. 1999. Cerebral amyloid angiopathy-related hemorrhage: interaction of apolipoprotein E ε2 with putative clinical risk factors. Stroke 30: 1643-1646.
27. 27. ROSAND, J. et al. 1999. Cerebral amyloid angiopathy and warfarin-associated hemorrhage: a genetic and neuropathologic study [Abstr.]. Neurology 52(Suppl 2): A503.
28. 28. MANDYBUR, T.I. 1986. Cerebral amyloid angiopathy: the vascular pathology and complications. J. Neuropathol. Exp. Neurol. 45: 79-90.
29. 29. VINTERS, H.V. 1987. Cerebral amyloid angiopathy. A critical review. Stroke 18: 311-324.
30. 30. MCCARRON, M.O. et al. 1999. The apolipoprotein E ε2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J. Neuropathol. Exp. Neurol. 58: 711-718.